Skip to content

The Serum Angiotensin Converting Enzyme and Lysozyme Levels in Patients Non-infectious and Infectious Uveitis

Non-infectious and Infectious Uveitis Diagnosis

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02627209
Acronym
uveitis
Enrollment
280
Registered
2015-12-10
Start date
2014-06-30
Completion date
2017-01-31
Last updated
2015-12-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sarcoidosis, Tuberculosis

Keywords

Angiotensin converting enzyme, Lysozyme, Ankylosing spondylitis, Behcet's disease, Sarcoidosis, Syphilis, Tuberculosis, Ocular inflammation

Brief summary

This study evaluates the significance of differences in serum angiotensin converting enzyme and lysozyme levels of patients with ocular involvement of other autoimmune inflammatory and infectious diseases.

Detailed description

Increased serum levels of angiotensin converting enzyme and lysozyme are considered as inflammatory markers for diagnosis of sarcoidosis which is an autoimmune inflammatory disease. Sarcoidosis, ankylosing spondylitis and Behcet's disease are the most common autoimmune inflammatory diseases involving the eye. Elevated serum angiotensin converting enzyme levels have also been reported in tuberculosis. Syphilis and tuberculosis are the most common infectious diseases involving the eye.

Interventions

OTHERspectrophotometric assay

measurement of enzyme activity in the serum

OTHERradial immunodiffusion

measurement of the precipitated ring diameters showing enzyme activity in the serum

Sponsors

Ozlem Sahin
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
9 Years to 86 Years
Healthy volunteers
No

Inclusion criteria

* Subjects have ocular inflammation diagnosed as sarcoidosis, ankylosing spondylitis, behcet's disease * Subjects have ocular infection diagnosed as tuberculosis and syphilis * Subjects have refractive errors only

Exclusion criteria

* Subjects using ACE inhibitors, systemic steroids, immunosuppressive or immunomodulatory therapies

Design outcomes

Primary

MeasureTime frame
Analysis of serum angiotensin converting enzyme level1 day

Secondary

MeasureTime frame
Analysis of serum lysozyme level1 day

Countries

Turkey (Türkiye)

Contacts

Primary Contactozlem sahin, MD
ozlem1158@yahoo.com90-537-5523064
Backup ContactEda Karaismailoglu, MS
edaozturk@yahoo.com90-533-3097848

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 14, 2026